Medical devices, healthcare technology and the business of care
510(k) clearance · K263582

KeriFlex MCP and PIP Finger Joint Prostheses

Keri Medical SA · Decision date Oct 29, 2026

MEDTECHLEDGER EXPLANATIONK263582

What did the FDA decide?

FDA recorded a decision of SESE for K263582, a 510(k) premarket notification submitted by Keri Medical SA of Plan-Les-Ouates, Switzerland, covering the KeriFlex® MCP and PIP Finger Joint Prostheses. The decision date is 2026-10-29; the same record lists a receipt date of 09/30/2026, product code KYJ, and orthopedic review panel. In 510(k) terms, SESE denotes a cleared premarket notification rather than a PMA approval.

The record identifies the device as a finger joint prosthesis line spanning metacarpophalangeal and proximal interphalangeal applications, but the available data do not describe materials, fixation, sizes, or indications for use. The listed summary designation indicates a 510(k) summary exists, yet its contents are not included here. No predicate device, substantial-equivalence basis, or clinical data are available, so the scope of the clearance beyond the named device family remains unknown.

Industry researchers should treat this as a dated clearance record only. The public page already displays the original FDA fields; any labeling, patient-selection, or performance details would need to be read from the underlying FDA documents rather than inferred from this entry.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Oct 29, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263582
Regulatory pathway
510(k) premarket notification
Product code
KYJ
Decision code
SESE
Decision date
Oct 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, Finger, Constrained, Polymer.

Product code
KYJ
FDA device class
2

FDA decision timeline

  1. K263582 received

    Application receipt date recorded by FDA.

  2. K263582 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Keri Medical SA

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Plan-Les-Ouates

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records